VEGFR-2-IN-89
VEGFR-2-IN-89 is a VEGFR-2 inhibitor with an IC50 of 77 nM. VEGFR-2-IN-89 potently inhibits c-Met kinase activity with an IC50 of 0.152 μM, and also exhibits good inhibitory activity against EGFR (IC50 = 0.269 μM) and PDGFR-β kinase (IC50 = 0.301 μM). VEGFR-2-IN-89 displays anticancer activity against liver cancer. VEGFR-2-IN-89 can be used in the research of hepatocellular carcinoma.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Formel: C21H17N5O3
- Molecular Weight:387.39
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Alle VEGFR Isoform-spezifische Produkte anzeigen
MoreAlle EGFR Isoform-spezifische Produkte anzeigen
More
Biologische Aktivität
|
VEGFR2 77 nM (IC50) |
c-Met 0.152 μM (IC50) |
EGFR 0.269 μM (IC50) |
PDGFR-β 0.301 μM (IC50) |
VEGFR-2-IN-89 (Compound 6f) potently inhibits the proliferation of HepG-2 hepatocellular carcinoma cells with an IC50 of 8.32 μM; it exhibits moderate activity against another 5 cancer cell lines, shows low cytotoxicity toward WI-38 and L02 normal cells, and has a favorable selectivity index[1].
VEGFR-2-IN-89 potently inhibits VEGFR-2 kinase activity with an IC50 of 0.077 μM, exhibiting greater efficacy than Sorafenib (HY-10201)[1].
VEGFR-2-IN-89 potently inhibits c-Met kinase activity with an IC50 of 0.152 μM, and also exhibits favorable inhibitory activity against EGFR and PDGFR-β kinases[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
Molecular Weight 387.39
-
Formel C21H17N5O3
-
SMILES
O=C(N/N=C/C1=CC=C(C)O1)C2=CC=C(N/N=C3C(NC4=C\3C=CC=C4)=O)C=C2
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)